Lim Yan Ping, Go Maybelle K, Yew Wen Shan
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive, Singapore 117597, Singapore.
NUS Synthetic Biology for Clinical and Technological Innovation, Centre for Life Sciences, National University of Singapore, 28 Medical Drive, Singapore 117456, Singapore.
Molecules. 2016 Jun 22;21(6):806. doi: 10.3390/molecules21060806.
Polyketides are structurally and functionally diverse secondary metabolites that are biosynthesized by polyketide synthases (PKSs) using acyl-CoA precursors. Recent studies in the engineering and structural characterization of PKSs have facilitated the use of target enzymes as biocatalysts to produce novel functionally optimized polyketides. These compounds may serve as potential drug leads. This review summarizes the insights gained from research on type III PKSs, from the discovery of chalcone synthase in plants to novel PKSs in bacteria and fungi. To date, at least 15 families of type III PKSs have been characterized, highlighting the utility of PKSs in the development of natural product libraries for therapeutic development.
聚酮化合物是结构和功能多样的次生代谢产物,由聚酮合酶(PKSs)利用酰基辅酶A前体进行生物合成。最近关于PKSs的工程改造和结构表征的研究,促进了将目标酶用作生物催化剂来生产功能优化的新型聚酮化合物。这些化合物可能成为潜在的药物先导物。本综述总结了从对III型PKSs的研究中获得的见解,从植物中查尔酮合酶的发现到细菌和真菌中的新型PKSs。迄今为止,至少已鉴定出15个III型PKSs家族,突出了PKSs在开发用于治疗的天然产物文库中的作用。